Market News & Trends
Imugene Granted Patent for Novel Delivery Technology
Australian drug delivery technology company Imugene recently announced the acceptance of a key Chinese patent application for the company’s novel drug delivery technology Linguet (Patent…
PAREXEL International Acquires HERON Group
PAREXEL International Corporation recently announced it has acquired all of the outstanding equity securities of the HERON Group LTD, a life sciences consultancy that provides…
Pharma & Biotech Industries Headed Toward an Era of Reduced Profit Margins
In the face of reduced profit margins for the pharmaceutical and biotechnology sectors, an effective financial management strategy is central to maintain sustainable growth. New…
Revolutionary Autoinjector Pushes the Limits of High-Viscosity Drug Delivery
Oval Medical Technologies Ltd recently announced that a variety of 1100 cPs solutions (the thickness of motor oil) have been successfully delivered through a 25-G…
BASF & PETRONAS to Invest $500 Million
BASF and PETRONAS Chemicals Group Berhad intend to invest $500 million in an integrated aroma ingredients project at their existing joint venture site BASF PETRONAS…
BIND Therapeutics & AstraZeneca Announce Lucrative Worldwide Agreement
BIND Therapeutics and AstraZeneca recently announced it has entered into a strategic collaboration to develop and commercialize an Accurin, a targeted and programmable cancer nanomedicine…
Elite Pharmaceuticals Secures $10 Million Funding
Elite Pharmaceuticals, Inc. recently announced it has entered into a $10 million common stock purchase agreement with Lincoln Park Capital Fund, LLC, a Chicago-based institutional…
FDA Gives Breakthrough Designation to Merck Drug
Merck recently announced the US Food and Drug Administration (FDA) has designated lambrolizumab (MK-3475) as a Breakthrough Therapy for the treatment of patients with advanced…
GSK & Avalon to Form Up to 10 Biotechs in San Diego
GlaxoSmithKline PLC recently announced it will partner with venture capitalists from San Diego in an unusual deal worth up to $495 million to start several…
Metrics Offers New Proprietary Technology to Improve Taste, Stability & Deliver SR Characteristics
Metrics Inc. now offers proprietary technology to mask the taste of tablets. The company’s innovative Cleantaste technology enables polymer coating of individual drug crystals to…
mPhase Technologies to Pursue Licensing Opportunities for Delivery System
mPhase Technologies, Inc. recently announced that it is pursuing licensing opportunities for its Smart Drug Delivery System. mPhase recently filed a United States Letter Patent…
Starpharma Granted Lucrative Drug Delivery Patents
Starpharma Holdings Ltd recently announced it has been granted three new patents by the United States Patent and Trademark Office (USPTO), which strengthen and expand…
Xenon Exclusively Licenses Merck Compounds
Xenon recently announced that Merck, through an affiliate, has exercised its option to exclusively license small molecule compounds for a novel target for the potential…
Carticept Medical Wins 510(k) Clearance
Carticept Medical, Inc. recently announced it has received 510(k) clearance from the US FDA for its enhanced Navigator Delivery System (DS), the first and only…
FDA Makes Decision on Abuse-Deterrent Formulations of Oxycontin Drug Products
Grünenthal recently announced it is pleased with the US Food and Drug Administration's (FDA) recent decisions regarding abuse-deterrent formulations (ADF) and prescription opioids. In its…
Model-Independent Platform Accurately Predicts Drugs’ Stable States to Guide Reformulation for Enhanced Bioavailability
BEND, OR-- Agere Pharmaceuticals, Inc., a leading oral bioavailability contract research and manufacturing organization (CRO/CMO), announced today that it has enhanced the Agere drug delivery…
The New Mega Trends That Will Shape a Future Britain
In the future, 81% of people in the UK will be living in urban areas, there will be 200 million connected devices, and one in…
Unilife Develops Customized Device to Enhance Patient Self-Injection of Biologics
Unilife Corporation recently announced the development of the Unifill Assure, a customized device from its Unifill platform of ready-to-fill (prefilled) syringes that is designed to…
nSpire Health Announces Next-Generation Respiratory Clinical Trial eDiary
nSpire Health Inc. recently announced the introduction of PROLogic(TM), its latest eDiary for respiratory clinical trials. Based on the PiKoLogic(TM) ePRO device platform, PROLogic provides…
BD Announces FDA 510(k) Clearance & Commercial Launch
BD Medical, a segment of BD (Becton, Dickinson and Company) recently announced the commercial launch of a new passive needle guard technology, BD UltraSafe PLUS.…
